Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy

PURPOSE: To investigate the 2-year outcomes of three monthly intravitreal ranibizumab injections followed by as-needed reinjections to treat polypoidal choroidal vasculopathy (PCV). METHODS: Seventy-five consecutive eyes with naïve symptomatic PCV with 2 years of follow-up after treatment were studi...

詳細記述

保存先:
書誌詳細
主要な著者: Hikichi, Taiichi, Higuchi, Makoto, Matsushita, Takuro, Kosaka, Shoko, Matsushita, Reiko, Takami, Kimitaka, Ohtsuka, Hideo, Kitamei, Hirokuni, Shioya, Shoko
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2013
主題:
Clinical Science
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3632979/
https://ncbi.nlm.nih.gov/pubmed/23428984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2012-302652
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料